Ed Mahon of Spotlight PA
-
5 Things to Know About the Rise of Prison Sentences After Overdose Deaths in Pennsylvania
—
by
Proposals to give prosecutors more time to bring these cases have stalled in the Pennsylvania legislature.
-
A Pa. Mom’s Fight Reveals the Messy Reality of Treating Overdoses Like Homicides
—
by
Some Pennsylvania lawmakers want to give prosecutors more time to bring charges against people who supply drugs in fatal overdoses.
-
Supplying Drugs in Fatal Overdoses Has Led to Hundreds of Pa. Prison Sentences. Grieving Families Are Divided
—
by
Pennsylvania is a leader in prosecuting people for providing drugs used in fatal overdoses.
-
Why Pa. Pharmacies Keep Closing and How Lawmakers Want to Slow the Trend, Explained in 7 Stats
—
by
State lawmakers have tried to rein in pharmacy benefit managers, the corporate middlemen frequently blamed for the closures.
-
Drug Plan Middlemen Face New Oversight Push as Pa. Pharmacies Close
—
by
The new proposal would also ban ownership of pharmacy licenses by corporate middlemen accused of driving pharmacy closures.
-
Pennsylvania Opens Door for Opioid Funds to Support Overwhelmed Public Defenders
—
by
The move represents a victory for a range of groups, including advocates who argue public defenders play a vital role in helping people dealing with addiction.
-
Opioid Settlement Spending Faces Growing Scrutiny as Pennsylvania Awaits Millions More
—
by
Counties battle uncertainty over funding rules while advocates and families push for an increased say in opioid settlement spending decisions.
-
Pennsylvania Loses Hundreds of Pharmacies After a Law Promised Help
—
by
Lawmakers want to ensure the Shapiro admin is holding corporate middlemen, known as pharmacy benefit managers, accountable.
-
The Broader COVID Vaccine Recommendations Embraced by Pa., and How They Conflict With Federal Guidelines
—
by
Pennsylvania pharmacies can offer COVID-19 vaccines, but they and their patients are navigating competing guidelines for who should receive them.
-
Secretive Board Overseeing Pa.’s Billion-Dollar Opioid Response Invites Public to Speak for 1st Time
—
by
Following pressure, the powerful board overseeing Pennsylvania opioid settlement money allows public comment but faces continued criticism over transparency and representation.